{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:25:54Z","timestamp":1772889954609,"version":"3.50.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12035-016-9936-9","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T13:06:45Z","timestamp":1463663205000},"page":"3618-3632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Gulnara R.","family":"Khakimova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Kozina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerian G.","family":"Kucheryanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"Ugrumov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"9936_CR1","doi-asserted-by":"publisher","first-page":"III\/40","DOI":"10.1007\/s00415-002-1309-9","volume":"249 Suppl","author":"G Becker","year":"2002","unstructured":"Becker G, Muller A, Braune S et al (2002) Early diagnosis of Parkinson\u2019s disease. J Neurol 249 Suppl:III\/40\u2013III\/48. doi: 10.1007\/s00415-002-1309-9","journal-title":"J Neurol"},{"key":"9936_CR2","doi-asserted-by":"publisher","first-page":"iv2","DOI":"10.1007\/s00415-006-4002-6","volume":"253","author":"J Spiegel","year":"2006","unstructured":"Spiegel J, Storch A, Jost WH (2006) Early diagnosis of Parkinson\u2019s disease. J Neurol 253:iv2\u2013iv7. doi: 10.1007\/s00415-006-4002-6","journal-title":"J Neurol"},{"key":"9936_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0074-7742(10)90006-8","volume":"90","author":"A Gaenslen","year":"2010","unstructured":"Gaenslen A, Berg D (2010) Early diagnosis of Parkinson\u2019s disease. Int Rev Neurobiol 90:81\u201392. doi: 10.1016\/S0074-7742(10)90006-8","journal-title":"Int Rev Neurobiol"},{"key":"9936_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau De","year":"2006","unstructured":"De Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535. doi: 10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"9936_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386. doi: 10.1212\/01.wnl.0000247740.47667.03","journal-title":"Neurology"},{"key":"9936_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","volume":"255 Suppl","author":"G Alves","year":"2008","unstructured":"Alves G, Forsaa EB, Pedersen KF et al (2008) Epidemiology of Parkinson\u2019s disease. J Neurol 255 Suppl:18\u201332. doi: 10.1007\/s00415-008-5004-3","journal-title":"J Neurol"},{"key":"9936_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.euroneuro.2010.08.002","volume":"21","author":"S Campenhausen Von","year":"2011","unstructured":"Von Campenhausen S, Winter Y, Rodrigues e Silva A (2011) Costs of illness and care in Parkinson\u2019s disease: an evaluation in six countries. Eur Neuropsychopharmacol 21:180\u2013191. doi: 10.1016\/j.euroneuro.2010.08.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"9936_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","volume":"9","author":"W Thies","year":"2013","unstructured":"Thies W, Bleiler L, Association A, Alzheimer\u2019s A (2013) Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 9:208\u2013245. doi: 10.1016\/j.jalz.2013.02.003","journal-title":"Alzheimer\u2019s Dement"},{"key":"9936_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366\u2013375","journal-title":"Trends Neurosci"},{"key":"9936_CR10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","volume":"337","author":"Y Agid","year":"1991","unstructured":"Agid Y (1991) Parkinson\u2019s disease: pathophysiology. Lancet 337:1321\u20131324","journal-title":"Lancet"},{"key":"9936_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1353-8020(98)00012-1","volume":"4","author":"H Ehringer","year":"1998","unstructured":"Ehringer H, Hornykiewicz O (1998) Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Park Relat Disord 4:53\u201357","journal-title":"Park Relat Disord"},{"key":"9936_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-0-387-30382-6_2","volume-title":"Handb. Neurochem. Mol. Neurobiol","author":"MV Ugrumov","year":"2008","unstructured":"Ugrumov MV (2008) Brain neurons partly expressing monoaminergic phenotype: distribution, development, and functional significance in norm and pathology. In: Lajtha A, Vizi ES (eds) Handb. Neurochem. Mol. Neurobiol. Springer, US, pp 21\u201373"},{"key":"9936_CR13","first-page":"395","volume":"110","author":"ES Musiek","year":"2013","unstructured":"Musiek ES, Schindler SE (2013) Alzheimer disease: current concepts & future directions. Mo Med 110:395\u2013400","journal-title":"Mo Med"},{"key":"9936_CR14","first-page":"406","volume":"110","author":"AW Willis","year":"2013","unstructured":"Willis AW (2013) Parkinson disease in the elderly adult. Mo Med 110:406\u2013410","journal-title":"Mo Med"},{"key":"9936_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/brain\/awm304","volume":"131","author":"M Bogdanov","year":"2008","unstructured":"Bogdanov M, Matson WR, Wang L et al (2008) Metabolomic profiling to develop blood biomarkers for Parkinson\u2019s disease. Brain 131:389\u2013396. doi: 10.1093\/brain\/awm304","journal-title":"Brain"},{"key":"9936_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1001\/archneurol.2010.321","volume":"68","author":"Y Wu","year":"2011","unstructured":"Wu Y, Le W, Jankovic J et al (2011) Preclinical biomarkers of Parkinson disease. Arch Neurol 68:22\u201330. doi: 10.1001\/archneurol.2010.321","journal-title":"Arch Neurol"},{"key":"9936_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","volume":"9","author":"L Parnetti","year":"2013","unstructured":"Parnetti L, Castrioto A, Chiasserini D et al (2013) Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 9:131\u2013140. doi: 10.1038\/nrneurol.2013.10","journal-title":"Nat Rev Neurol"},{"key":"9936_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma S, Moon CS, Khogali A et al (2013) Biomarkers in Parkinson\u2019s disease (recent update). Neurochem Int 63:201\u2013229. doi: 10.1016\/j.neuint.2013.06.005","journal-title":"Neurochem Int"},{"key":"9936_CR19","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi MM, Ardah MT et al (2010) Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75:1766\u20131772. doi: 10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"key":"9936_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.1090349","volume":"302","author":"ST DeKosky","year":"2003","unstructured":"DeKosky ST, Marek K (2003) Looking backward to move forward: early detection of neurodegenerative disorders. Science 302:830\u2013834. doi: 10.1126\/science.1090349","journal-title":"Science"},{"key":"9936_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/nedt.2007.3.1.145","volume":"3","author":"C Pellicano","year":"2007","unstructured":"Pellicano C, Benincasa D, Pisani V et al (2007) Prodromal non-motor symptoms of Parkinson\u2019s disease. Neuropsychiatr Dis Treat 3:145\u2013151. doi: 10.2147\/nedt.2007.3.1.145","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9936_CR22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.5692\/clinicalneurol.53.974","volume":"53","author":"K Takahashi","year":"2013","unstructured":"Takahashi K (2013) Non-motor symptoms in premotor phase of Parkinson disease. Rinsho Shinkeigaku 53:974\u2013976","journal-title":"Rinsho Shinkeigaku"},{"key":"9936_CR23","doi-asserted-by":"crossref","unstructured":"Berg D (2006) Marker for a preclinical diagnosis of Parkinson\u2019s disease as a basis for neuroprotection. J Neural Transm Suppl 71:123\u201332","DOI":"10.1007\/978-3-211-33328-0_14"},{"key":"9936_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0002-9378(75)90079-4","volume":"121","author":"RK Freeman","year":"1975","unstructured":"Freeman RK (1975) The use of the oxytocin challenge test for antepartum clinical evaluation of uteroplacental respiratory function. Am J Obs Gynecol 121:481\u2013489","journal-title":"Am J Obs Gynecol"},{"key":"9936_CR25","first-page":"732","volume":"55","author":"RD Gambrell","year":"1980","unstructured":"Gambrell RD, Massey FM, Castaneda TA et al (1980) Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 55:732\u2013738","journal-title":"Obstet Gynecol"},{"key":"9936_CR26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0002-8703(81)90030-2","volume":"102","author":"R Ginsburg","year":"1981","unstructured":"Ginsburg R, Bristow MR, Kantrowitz N et al (1981) Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Hear J 102:819\u2013822","journal-title":"Am Hear J"},{"key":"9936_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1378\/chest.92.2.313","volume":"92","author":"P Lebecque","year":"1987","unstructured":"Lebecque P, Spier S, Lapierre JG et al (1987) Histamine challenge test in children using forced oscillation to measure total respiratory resistance. Chest 92:313\u2013318","journal-title":"Chest"},{"key":"9936_CR28","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s00125-009-1407-7","volume":"52","author":"LS Phillips","year":"2009","unstructured":"Phillips LS, Ziemer DC, Kolm P et al (2009) Glucose challenge test screening for prediabetes and undiagnosed diabetes. Diabetologia 52:1798\u20131807. doi: 10.1007\/s00125-009-1407-7","journal-title":"Diabetologia"},{"key":"9936_CR29","first-page":"312","volume":"61","author":"P Witek","year":"2010","unstructured":"Witek P, Zgliczy\u0144ski W, Zieli\u0144ski G, Jeske W (2010) The role of combined low-dose dexamethasone suppression test and desmopressin stimulation test in the diagnosis of persistent Cushing\u2019s disease. Case report. Endokrynol Pol 61:312\u2013317","journal-title":"Endokrynol Pol"},{"key":"9936_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EJE-12-0584","volume":"168","author":"V Gasco","year":"2013","unstructured":"Gasco V, Beccuti G, Baldini C et al (2013) Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults. Eur J Endocrinol 168:23\u201330. doi: 10.1530\/EJE-12-0584","journal-title":"Eur J Endocrinol"},{"key":"9936_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamainternmed.2013.850","volume":"173","author":"LK Hermann","year":"2013","unstructured":"Hermann LK, Newman DH, Pleasant WA et al (2013) Yield of routine provocative cardiac testing among patients in an emergency department-based chest pain unit. JAMA Intern Med 173:1128\u20131133. doi: 10.1001\/jamainternmed.2013.850","journal-title":"JAMA Intern Med"},{"key":"9936_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaip.2015.02.005","volume":"3","author":"C Porsbjerg","year":"2015","unstructured":"Porsbjerg C, Sverrild A, Backer V (2015) Combining the mannitol test and FeNO in the assessment of poorly controlled asthma. J Allergy Clin Immunol Pract 3:1\u20137. doi: 10.1016\/j.jaip.2015.02.005","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9936_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4068\/cmj.2015.51.1.33","volume":"51","author":"N Rhee","year":"2015","unstructured":"Rhee N, Oh KY, Yang EM, Kim CJ (2015) Growth hormone responses to provocative tests in children with short stature. Chonnam Med J 51:33\u201338. doi: 10.4068\/cmj.2015.51.1.33","journal-title":"Chonnam Med J"},{"key":"9936_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.diagmicrobio.2015.03.008","volume":"82","author":"Q Sun","year":"2015","unstructured":"Sun Q, Sha W, Gui X-W et al (2015) Drug-induced lymphocyte stimulation test in the prediction of drug-induced hypersensitivity to antituberculosis drugs. Diagn Microbiol Infect Dis 82:172\u2013176. doi: 10.1016\/j.diagmicrobio.2015.03.008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9936_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RKW, Huston JP (2001) Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 125:109\u2013125. doi: 10.1016\/S0166-4328(01)00309-6","journal-title":"Behav Brain Res"},{"key":"9936_CR36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(25)27412-2","volume":"153","author":"RH Rech","year":"1966","unstructured":"Rech RH, Borys HK, Moore KE (1966) Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine. J Pharmacol Exp Ther 153:412\u2013419","journal-title":"J Pharmacol Exp Ther"},{"key":"9936_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.1973.tb08218.x","volume":"48","author":"DA Hutchins","year":"1973","unstructured":"Hutchins DA, Rogers KJ (1973) Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain. Br J Pharmacol 48:19\u201329","journal-title":"Br J Pharmacol"},{"key":"9936_CR38","first-page":"111","volume":"123","author":"D Relationships","year":"1978","unstructured":"Relationships D (1978) Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after \u03b1-methyl-p-tyrosine; time- and dose-response relationships. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 123:111\u2013123","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9936_CR39","volume-title":"Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2012","unstructured":"Paxinos G, Franklin K (2012) Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates, 4th edn. Elsevier\/Academic Press, Amsterdam","edition":"4"},{"key":"9936_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","volume":"181","author":"MV Ugrumov","year":"2011","unstructured":"Ugrumov MV, Khaindrava VG, Kozina EA et al (2011) Modeling of presymptomatic and symptomatic stages of parkinsonism in mice. Neuroscience 181:175\u2013188. doi: 10.1016\/j.neuroscience.2011.03.007","journal-title":"Neuroscience"},{"key":"9936_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01244661","volume":"34","author":"A Carlsson","year":"1973","unstructured":"Carlsson A, Lindqvist M (1973) In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. J Neural Transm 34:79\u201391","journal-title":"J Neural Transm"},{"key":"9936_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00429-008-0197-x","volume":"213","author":"M Izvolskaia","year":"2009","unstructured":"Izvolskaia M, Duittoz AH, Tillet Y, Ugrumov MV (2009) The influence of catecholamine on the migration of gonadotropin-releasing hormone-producing neurons in the rat foetuses. Brain Struct Funct 213:289\u2013300. doi: 10.1007\/s00429-008-0197-x","journal-title":"Brain Struct Funct"},{"key":"9936_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jchemneu.2009.08.004","volume":"38","author":"MV Ugrumov","year":"2009","unstructured":"Ugrumov MV (2009) Non-dopaminergic neurons partly expressing dopaminergic phenotype: distribution in the brain, development and functional significance. J Chem Neuroanat 38:241\u2013256. doi: 10.1016\/j.jchemneu.2009.08.004","journal-title":"J Chem Neuroanat"},{"key":"9936_CR44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0361-9230(84)90128-X","volume":"13","author":"M Arluison","year":"1984","unstructured":"Arluison M, Dietl M, Thibault J (1984) Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: a topographical study. Brain Res Bull 13:269\u2013285","journal-title":"Brain Res Bull"},{"key":"9936_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-12-411512-5.00004-X","volume":"68","author":"MV Ugrumov","year":"2013","unstructured":"Ugrumov MV (2013) Brain neurons partly expressing dopaminergic phenotype. Adv Pharmacol 68:37\u201391. doi: 10.1016\/B978-0-12-411512-5.00004-X","journal-title":"Adv Pharmacol"},{"key":"9936_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.04.040","volume":"140","author":"A Gobert","year":"2004","unstructured":"Gobert A, Billiras R, Cistarelli L, Millan MJ (2004) Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors. J Neurosci Methods 140:141\u2013152. doi: 10.1016\/j.jneumeth.2004.04.040","journal-title":"J Neurosci Methods"},{"key":"9936_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1023863003093","volume":"18","author":"R Kurosaki","year":"2003","unstructured":"Kurosaki R, Muramatsu Y, Watanabe H et al (2003) Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Metab Brain Dis 18:139\u2013146","journal-title":"Metab Brain Dis"},{"key":"9936_CR48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ar.1090940210","volume":"94","author":"M Abercrombie","year":"1946","unstructured":"Abercrombie M (1946) Estimation of nuclear population from microtome sections. Anat Rec 94:239\u2013247","journal-title":"Anat Rec"},{"key":"9936_CR49","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","volume":"7","author":"CR Gerfen","year":"1987","unstructured":"Gerfen CR, Herkenham M, Thibault J (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915\u20133934","journal-title":"J Neurosci"},{"key":"9936_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1134\/S1054661810030119","volume":"20","author":"IB Gurevich","year":"2010","unstructured":"Gurevich IB, Kozina EA, Myagkov AA et al (2010) Automating extraction and analysis of dopaminergic axon terminals in images of frontal slices of the striatum. Pattern Recognit Image Anal Adv Math Theory Appl 20:349\u2013359. doi: 10.1134\/S1054661810030119","journal-title":"Pattern Recognit Image Anal Adv Math Theory Appl"},{"key":"9936_CR51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/B978-0-12-185255-9.50016-X","volume":"3","author":"AJ Smolen","year":"1990","unstructured":"Smolen AJ (1990) Image analytic techniques for quantification of immunohistochemical staining in the nervous system. Methods Neurosci 3:208\u2013229","journal-title":"Methods Neurosci"},{"key":"9936_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01246353","volume":"22","author":"RC Borke","year":"1993","unstructured":"Borke RC, Curtis M, Ginsberg C (1993) Choline acetyltransferase and calcitonin gene-related peptide immunoreactivity in motoneurons after different types of nerve injury. J Neurocytol 22:141\u2013153","journal-title":"J Neurocytol"},{"key":"9936_CR53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0169-328X(94)00288-P","volume":"30","author":"LR Lucas","year":"1995","unstructured":"Lucas LR, Harlan RE (1995) Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum. Brain Res Mol Brain Res 30:181\u2013195","journal-title":"Brain Res Mol Brain Res"},{"key":"9936_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-079X.2009.00704.x","volume":"47","author":"HM Chang","year":"2009","unstructured":"Chang HM, Wu UI, Lan CT (2009) Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats. J Pineal Res 47:211\u2013220. doi: 10.1111\/j.1600-079X.2009.00704.x","journal-title":"J Pineal Res"},{"key":"9936_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1096-9861(20000918)425:2<167::AID-CNE1>3.0.CO;2-K","volume":"425","author":"IS Balan","year":"2000","unstructured":"Balan IS, Ugrumov MV, Calas A et al (2000) Tyrosine hydroxylase-expressing and\/or aromatic L-amino acid decarboxylase-expressing neurons in the mediobasal hypothalamus of perinatal rats: differentiation and sexual dimorphism. J Comp Neurol 425:167\u2013176","journal-title":"J Comp Neurol"},{"key":"9936_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00429-010-0290-9","volume":"215","author":"MA Abramova","year":"2011","unstructured":"Abramova MA, Calas A, Ugrumov MV (2011) Vasopressinergic neurons of the supraoptic nucleus in perinatal rats: reaction to osmotic stimulation and its regulation. Brain Struct Funct 215:195\u2013207. doi: 10.1007\/s00429-010-0290-9","journal-title":"Brain Struct Funct"},{"key":"9936_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)27006-9","volume":"148","author":"M Levitt","year":"1965","unstructured":"Levitt M, Spector S, Sjoerdsma A, Udenfriend S (1965) Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther 148:1\u20138","journal-title":"J Pharmacol Exp Ther"},{"key":"9936_CR58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O et al (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"9936_CR59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257\u2013269","journal-title":"Neurodegeneration"},{"key":"9936_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/exnr.1998.6993","volume":"156","author":"I Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M et al (1999) The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50\u201361. doi: 10.1006\/exnr.1998.6993","journal-title":"Exp Neurol"},{"key":"9936_CR61","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"D-C Wu","year":"2003","unstructured":"Wu D-C, Teismann P, Tieu K et al (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 100:6145\u20136150. doi: 10.1073\/pnas.0937239100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9936_CR62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","volume":"98","author":"DW Luchtman","year":"2009","unstructured":"Luchtman DW, Shao D, Song C (2009) Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease. Physiol Behav 98:130\u2013138. doi: 10.1016\/j.physbeh.2009.04.021","journal-title":"Physiol Behav"},{"key":"9936_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795. doi: 10.1038\/nature05292","journal-title":"Nature"},{"key":"9936_CR64","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/exnr.1998.6995","volume":"155","author":"E Bezard","year":"1999","unstructured":"Bezard E, Gross CE, Fournier MC et al (1999) Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155:268\u2013273. doi: 10.1006\/exnr.1998.6995","journal-title":"Exp Neurol"},{"key":"9936_CR65","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1073\/pnas.0501282102","volume":"102","author":"RH Kim","year":"2005","unstructured":"Kim RH, Smith PD, Aleyasin H et al (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A 102:5215\u20135220. doi: 10.1073\/pnas.0501282102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9936_CR66","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M et al (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99:14524\u201314529. doi: 10.1073\/pnas.172514599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9936_CR67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0024-3205(85)90066-9","volume":"36","author":"RW Fuller","year":"1985","unstructured":"Fuller RW, Steranka LR (1985) Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents. Life Sci 36:243\u2013247","journal-title":"Life Sci"},{"key":"9936_CR68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","volume":"527","author":"NA Seniuk","year":"1990","unstructured":"Seniuk NA, Tatton WG, Greenwood CE (1990) Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res 527:7\u201320","journal-title":"Brain Res"},{"key":"9936_CR69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-12-374028-1.00003-8","volume-title":"Parkinson\u2019s disease: molecular and therapeutic insights from model systems","author":"L Petrucelli","year":"2008","unstructured":"Petrucelli L, Dickson DW (2008) Neuropathology of Parkinson\u2019s disease. In: Nass R, Przedborski S (eds) Parkinson\u2019s disease: molecular and therapeutic insights from model systems. Elsevier Inc, Amsterdam, pp 35\u201348"},{"key":"9936_CR70","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M et al (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763\u20131771","journal-title":"J Neurosci"},{"key":"9936_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","volume":"39","author":"P Teismann","year":"2001","unstructured":"Teismann P, Ferger B (2001) Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson\u2019s disease. Synapse 39:167\u2013174. doi: 10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","journal-title":"Synapse"},{"key":"9936_CR72","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S et al (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 98:14669\u201314674. doi: 10.1073\/pnas.251341998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9936_CR73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","volume":"24","author":"DC German","year":"1988","unstructured":"German DC, Dubach M, Askari S et al (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience 24:161\u2013174","journal-title":"Neuroscience"},{"key":"9936_CR74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","volume":"14","author":"E Rousselet","year":"2003","unstructured":"Rousselet E, Joubert C, Callebert J et al (2003) Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis 14:218\u2013228","journal-title":"Neurobiol Dis"},{"key":"9936_CR75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02337479","volume":"8","author":"R Sandyk","year":"1987","unstructured":"Sandyk R, Iacono RP, Bamford CR (1987) The hypothalamus in Parkinson disease. Ital J Neurol Sci 8:227\u2013234","journal-title":"Ital J Neurol Sci"},{"key":"9936_CR76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Blumbergs PC, Cotton RG et al (1990) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease. Brain Res 510:104\u2013107","journal-title":"Brain Res"},{"key":"9936_CR77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)26954-3","volume":"147","author":"S Spector","year":"1965","unstructured":"Spector S, Sjoerdsma A, Udenfriend S (1965) Blockade of endogenous norepinephrine synthesis by agr-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J Pharmacol Exp Ther 147:86\u201395","journal-title":"J Pharmacol Exp Ther"},{"key":"9936_CR78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-3565(25)27596-6","volume":"156","author":"KE Moore","year":"1967","unstructured":"Moore KE, Rech RH (1967) Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression. J Pharmacol Exp Ther 156:70\u201375","journal-title":"J Pharmacol Exp Ther"},{"key":"9936_CR79","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.2042-7158.1968.tb09831.x","volume":"20","author":"KE Moore","year":"1968","unstructured":"Moore KE (1968) Behavioural effects of alpha-methyltyrosine administered in the diets of mice pretreated with a monoamine oxidase inhibitor. J Pharm Pharmacol 20:656\u2013657","journal-title":"J Pharm Pharmacol"},{"key":"9936_CR80","first-page":"166","volume":"178","author":"JA Dominic","year":"1969","unstructured":"Dominic JA, Moore KE (1969) Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice. Arch Int Pharmacodyn Ther 178:166\u2013176","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"9936_CR81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00455973","volume":"10","author":"H Corrodi","year":"1966","unstructured":"Corrodi H, Hanson LC (1966) Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia 10:116\u2013125","journal-title":"Psychopharmacologia"},{"key":"9936_CR82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-3057(76)90217-3","volume":"4","author":"AC Dolphin","year":"1976","unstructured":"Dolphin AC, Jenner P, Marsden CD (1976) The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice. Pharmacol Biochem Behav 4:661\u2013670","journal-title":"Pharmacol Biochem Behav"},{"key":"9936_CR83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02259662","volume":"9","author":"E Lorenc-Koci","year":"1995","unstructured":"Lorenc-Koci E, Ossowska K, Wardas J, Wolfarth S (1995) Does reserpine induce parkinsonian rigidity? J Neural Transm Park Dis Dement Sect 9:211\u2013223","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"9936_CR84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/187152408786848102","volume":"8","author":"OJN Bloemen","year":"2008","unstructured":"Bloemen OJN, De Koning MB, Boot E et al (2008) Challenge and therapeutic studies using alpha-methyl-para-tyrosine (AMPT) in neuropsychiatric disorders: a review. Cent Nerv Syst Agents Med Chem (Formerly Curr Med Chem Nerv Syst Agents) 8:249\u2013256","journal-title":"Cent Nerv Syst Agents Med Chem (Formerly Curr Med Chem Nerv Syst Agents)"},{"key":"9936_CR85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199011000-00010","volume":"212","author":"RR Perry","year":"1990","unstructured":"Perry RR, Keiser HR, Norton JA et al (1990) Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg 212:621\u2013628","journal-title":"Ann Surg"},{"key":"9936_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0006-3223(96)00331-9","volume":"42","author":"SM Stine","year":"1997","unstructured":"Stine SM, Krystal JH, Petrakis IL et al (1997) Effect of alpha-methyl-para-tyrosine on response to cocaine challenge. Biol Psychiatry 42:181\u2013190. doi: 10.1016\/S0006-3223(96)00331-9","journal-title":"Biol Psychiatry"},{"key":"9936_CR87","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/jcan.2002.124150","volume":"31","author":"MC Turner","year":"1992","unstructured":"Turner MC, Lieberman E, DeQuattro V (1992) The perioperative management of pheochromocytoma in children. Clin Pediatr (Phila) 31:583\u2013589. doi: 10.1053\/jcan.2002.124150","journal-title":"Clin Pediatr (Phila)"},{"key":"9936_CR88","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1172\/JCI105754","volume":"47","author":"K Engelman","year":"1968","unstructured":"Engelman K, Horwitz D, Jequier E, Sjoerdsma A (1968) Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J Clin Invest 47:577\u2013594. doi: 10.1172\/JCI105754","journal-title":"J Clin Invest"},{"key":"9936_CR89","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(68)91579-1","volume":"2","author":"NF Jones","year":"1968","unstructured":"Jones NF, Walker G, Ruthven CR, Sandler M (1968) Alpha-methyl-p-tyrosine in the management of phaeochromocytoma. Lancet (London, England) 2:1105\u20131109","journal-title":"Lancet (London, England)"},{"key":"9936_CR90","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s00259-008-0739-8","volume":"35","author":"E Boot","year":"2008","unstructured":"Boot E, Booij J, Hasler G et al (2008) AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. Eur J Nucl Med Mol Imaging 35:1350\u20131356. doi: 10.1007\/s00259-008-0739-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9936_CR91","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/sj.npp.1301508","volume":"33","author":"E Boot","year":"2008","unstructured":"Boot E, Booij J, Zinkstok J et al (2008) Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology 33:1252\u20131258. doi: 10.1038\/sj.npp.1301508","journal-title":"Neuropsychopharmacology"},{"key":"9936_CR92","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-198212000-00005","volume":"5","author":"AE Lang","year":"1982","unstructured":"Lang AE, Marsden CD (1982) Alpha methylparatyrosine and tetrabenazine in movement disorders. Clin Neuropharmacol 5:375\u2013387","journal-title":"Clin Neuropharmacol"},{"key":"9936_CR93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1176\/jnp.2007.19.1.65","volume":"19","author":"R Ankenman","year":"2007","unstructured":"Ankenman R, Salvatore MF (2007) Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia. J Neuropsychiatry Clin Neurosci 19:65\u201369. doi: 10.1176\/jnp.2007.19.1.65","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9936_CR94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01217333","volume":"210","author":"W Birkmayer","year":"1967","unstructured":"Birkmayer W, Mentasti M (1967) Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes). Arch Psychiatr Nervenkr 210:29\u201335","journal-title":"Arch Psychiatr Nervenkr"},{"key":"9936_CR95","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1528-1157.1989.tb05480.x","volume":"30","author":"RA Hrachovy","year":"1989","unstructured":"Hrachovy RA, Frost JDJ, Glaze DG, Rose D (1989) Treatment of infantile spasms with methysergide and alpha-methylparatyrosine. Epilepsia 30:607\u2013610","journal-title":"Epilepsia"},{"key":"9936_CR96","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0893-133X(97)00043-2","volume":"17","author":"M Laruelle","year":"1997","unstructured":"Laruelle M, D\u2019Souza CD, Baldwin RM et al (1997) Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 17:162\u2013174. doi: 10.1016\/S0893-133X(97)00043-2","journal-title":"Neuropsychopharmacology"},{"key":"9936_CR97","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/sj.mp.4001423","volume":"8","author":"L Booij","year":"2003","unstructured":"Booij L, Van der Does AJ, Riedel WJ (2003) Monoamine depletion in psychiatric and healthy populations: review. Mol Psychiatry 8:951\u2013973. doi: 10.1038\/sj.mp.4001423","journal-title":"Mol Psychiatry"},{"key":"9936_CR98","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U et al (1995) Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology 45:182\u2013184","journal-title":"Neurology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9936-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9936-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9936-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9936-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:48:49Z","timestamp":1748965729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9936-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["9936"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9936-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]}}}